Eli Lilly And Company (LLY) closed at $1437.29 on November 11, 2026, up 0.3% from the previous close, on volume of 1,681,548 shares (30-day average 2,716,497).
Data as of November 11, 2026.
11-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 3, 2026 | Put Butterfly | 19-Mar-27800 : 1000[2x] : 1200 P | 3,216 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Democratic senators probe gifts to RFK Jr. from large donor to his presidential campaign
Seeking Alpha News (Wed, 11-Nov 3:39 PM ET)
PRNewswire (Wed, 11-Nov 9:45 AM ET)
3 Mega-Cap Stocks with a ‘Perfect 10’ Smart Score
TipRanks (Wed, 11-Nov 9:11 AM ET)
TipRanks (Wed, 11-Nov 8:50 AM ET)
4 stocks to watch on Wednesday: LLY, BABA, PYPL, and NVDA
Seeking Alpha News (Wed, 11-Nov 8:47 AM ET)
Apple Shares (AAPL) Look Expensive Heading into 2027
TipRanks (Wed, 11-Nov 8:15 AM ET)
Lilly sued over alleged firing of sales rep for complaints about Mounjaro misbranding
Seeking Alpha News (Wed, 11-Nov 7:12 AM ET)
Hims & Hers Health Faces Legal Woes as Five States Join FTC Lawsuit over Privacy Practices
TipRanks (Wed, 11-Nov 3:59 AM ET)
TipRanks (Tue, 10-Nov 1:06 PM ET)
Hims & Hers (HIMS) Needs Better Profits to Justify Its Price
TipRanks (Tue, 10-Nov 10:07 AM ET)
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly And Company trades on the NYSE stock market under the symbol LLY.
As of November 11, 2026, LLY stock price climbed to $1,437.29 with 1,681,548 million shares trading.
LLY has a beta of 0.02, meaning it tends to be less sensitive to market movements. LLY has a correlation of 0.00 to the broad based SPY ETF.
LLY has a market cap of $1.28 trillion. This is considered a Mega Cap stock.
Last quarter Eli Lilly And Company reported $24 billion in Revenue and $7.48 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $1.12.
In the last 3 years, LLY traded as high as $1,453.00 and as low as $561.65.
The top ETF exchange traded funds that LLY belongs to (by Net Assets): VTI, VOO, IVV, SPY, VUG.
LLY has outperformed the market in the last year with a price return of +49.4% while the SPY ETF gained +12.6%. LLY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +16.8% and +12.1%, respectively, while the SPY returned -1.5% and -1.3%, respectively.
LLY support price is $1,399.88 and resistance is $1,464.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LLY shares will trade within this expected range on the day.
